CurrentEndo
Get Weekly

Topic · page 20 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 761–800 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

  1. Diabet Med

    High prevalence of maturity‐onset diabetes of the young in the Czech Republic: A 25‐year nationwide registry‐based study

    Cohort study

  2. Endocr Pract

    Sodium–Glucose Co-Transporter-2 Inhibitors and Cardiovascular Effects in Kidney Transplant Recipients With Diabetes Mellitus

    Cohort study

  3. Diabetes Res Clin Pract

    Cost-effectiveness analysis of oral semaglutide versus subcutaneous dulaglutide in patients with type 2 diabetes mellitus: A Markov model study

    Research article

  4. Nat Med

    Genetic regulation across germline and somatic variation on the Y chromosome contributes to type 2 diabetes

    Research article

  5. Diabetes Res Clin Pract

    The temporal interplay between physical activity, emotional well-being, and health-related quality of life in individuals with recently diagnosed type 2 diabetes mellitus: a cross-lagged panel analysis

    Cohort study

  6. Diabetes Res Clin Pract

    Association of life’s essential 8 with cardiovascular outcomes and mortality in adults with prediabetes: mediating role of inflammatory biomarkers

    Cohort study

  7. Diabetes Obes Metab

    Comparative effectiveness of continuous positive airway pressure and glucagon‐like peptide‐1 receptor agonists in obstructive sleep apnea: A network meta‐analysis of randomised trials

    Meta-analysis

  8. Diabetes Obes Metab

    Impact of specialised endocrinology care on metabolic control and healthcare utilisation outcomes after kidney transplantation in patients with diabetes: A 12‐month observational cohort study

    Cohort study

  9. Diabetes Obes Metab

    Real‐world predictors of progression to type 2 diabetes among adults with prediabetes

    Case-control study

  10. Diabetes Res Clin Pract

    Thiazolidinedione and reduced epilepsy risk: A population-based study using target trial emulation

    Cohort study

  11. Cardiovasc Diabetol

    Erythrocytosis after SGLT2 inhibitor initiation and anticoagulated outcomes in atrial fibrillation: a real-world analysis with counterfactual modeling

    Cohort study

  12. Obesity (Silver Spring)

    Adipose Tissue‐Derived Small Extracellular Vesicles in Plasma Reveal Molecular Circuitries Underlying Glucose Intolerance

    Mechanistic study

  13. Diabetes Obes Metab

    Comparative effectiveness of combination therapy with SGLT ‐2 inhibitors and GLP ‐1 RAs compared with SGLT ‐2 inhibitors in individuals with type 2 diabetes: A prevalent new‐user cohort study

    Cohort study

  14. Diabetologia

    Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA

    Cohort study

  15. Diabetes Res Clin Pract

    Chronic complication risk and benefits of fenofibrate in type 2 diabetes by a PPARα polymorphism (rs6008845, C/T): a FIELD trial substudy

    Secondary analysis

  16. Diabetes Res Clin Pract

    Liver fibrosis scores predict cardiovascular outcomes in myocardial infarction and non-obstructive coronary arteries patients with and without diabetes or prediabetes

    Cohort study

  17. Diabetes Res Clin Pract

    Glycaemic control remains central in type 2 diabetes mellitus management: key learnings from the latest International Diabetes Federation guidelines

    Guideline or statement

  18. Diabetes Res Clin Pract

    Glucagon-like peptide-1 receptor agonists and the risk of obesity-related cancers: a systematic review and meta-analysis

    Meta-analysis

  19. Diabetes Obes Metab

    Characterisation of real‐world patients who discontinued a glucagon‐like peptide‐1 agonist

    Cohort study

  20. J Clin Endocrinol Metab

    Impact of serum prolactin on cognitive function, brain structure, and function in type 2 diabetes mellitus

    Cross-sectional study

  21. Diabet Med

    Prognostic value of triglyceride‐derived metabolic parameters for micro‐ and macrovascular complications and mortality in individuals with type 2 diabetes: The Rio de Janeiro type 2 diabetes cohort study

    Cohort study

  22. Diabet Med

    The impact of sleep and movement behaviour on daily mood in people with type 2 diabetes: A smartphone‐based digital phenotyping study

    Research article

  23. Diabetes Care

    Impact of an Additional Pregnancy on the Natural History of Insulin Sensitivity, β-Cell Function, and Glycemia in Parous Women

    Cohort study

  24. Diabetes Obes Metab

    Associations of metformin and sulfonylurea on vascular complications in early‐ and late‐onset type 2 diabetes: A cohort study

    Cohort study

  25. Diabetes Obes Metab

    Baseline and 4‐year associations between prediabetes and kidney impairment: Insights from the ILERVAS cohort

    Cross-sectional study

  26. Diabetes Obes Metab

    Causal role of genetically predicted impairment of branched‐chain amino acid catabolism on insulin secretion and insulin resistance in type 2 diabetes

    Meta-analysis

  27. Diabetes Obes Metab

    Cost‐utility of once‐weekly insulin icodec versus once‐daily basal insulins for type 2 diabetes in China

    Research article

  28. Diabetes Obes Metab

    Hepatic and abdominal adiposity in type 2 diabetes as assessed with machine learning on computed tomography scans

    Cross-sectional study

  29. Diabetes Obes Metab

    Effect of lixisenatide on arterial stiffness in people with type 2 diabetes and kidney disease: Results of a randomised controlled trial

    Randomized controlled trial

  30. Obesity (Silver Spring)

    Impact of Vertical Sleeve Gastrectomy in Youth‐Onset Type 2 Diabetes: Changes in Glycemia, Insulin Sensitivity, and Secretion

    Cohort study

  31. Diabetes Res Clin Pract

    Cardiometabolic multimorbidity prevalence and mortality risks in Chinese old-old population: real-world evidence from continuing care retirement community

    Cohort study

  32. Diabetes Care

    Glucagon-Like Peptide 1 Receptor Agonists and Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients With Type 2 Diabetes

    Cohort study

  33. Diabetes Care

    National Trends in Expenditures on Glucose-Lowering Medications in U.S. Adults With Diabetes: 2000–2022

    Cross-sectional study

  34. Diabetes Res Clin Pract

    MicroRNAs modify relationships between hemoglobin A1c and race and ethnicity

    Secondary analysis

  35. Diabetes Res Clin Pract

    Precision staging of Type 2 diabetes through Hypergraph-Based multimorbidity Profiling: From hepatic disruption to cardiovascular escalation

    Cohort study

  36. Diabetes Obes Metab

    Real‐world persistence and dose titration of GLP ‐1 receptor agonists in type 2 diabetes: A UK population‐based cohort study by obesity and cardiovascular disease status

    Cohort study

  37. Diabet Med

    Trends in global risk factors for the development of type 2 diabetes mellitus: Evidence from the global burden of disease study, 1990–2021

    Secondary analysis

  38. Diabetes Res Clin Pract

    Remission of type 2 diabetes depends on time since diagnosis and low-calorie diet composition: Results of a randomized controlled trial in individuals with overweight and obesity

    Randomized controlled trial

  39. Cardiovasc Diabetol

    Prognostic impact of metformin in diabetic patients undergoing a percutaneous coronary intervention (PCI): protective effect is modified by procedural complexity

    Cohort study

  40. Diabet Med

    Estimating the economic burden of diabetes in young adults: A global analysis based on the GBD 2021 and a value of statistical life year framework

    Research article

All 4,758 Briefs in ExploreShowing Briefs 761–800 of 4,758, newest first